Dabrafenib
Dabrafenib is a compound used as a serine/threonine-protein kinase B-Raf inhibitor for oncology research. It competitively inhibits V600E BRAF gene mutations which are characteristic in melanoma cancers. Inhibition of B-Raf proteins, by dabrafenib, interrupts mitogen-activated protein kinase/extracellular signal regulated kinase (MAPK/ERK) pathways, which regulate cell growth.This action halts cell proliferative activity and engages apoptosis.Product SpecificationsDabrafenibFormula: C23H20F3N5O2S2MW: 519.56 g/mol
Product Specifications
CAS Number
1195765-45-7
Molecular Weight
519.56 g/mol
Identity
D-210
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
102301J0-AAT 100 Tests
PacOrange Anti-human CD23 Antibody *EBVCS-5*
Sign In for Pricing
View Details 
MBS6507867-01 0.1 mg
Ki-67 (Antigen Identified by Monoclonal Antibody Ki-67, KIA, MKI67, Proliferation Related Ki-67 Antigen)
Sign In for Pricing
View Details MBS6507867-02 5x 0.1 mg
Ki-67 (Antigen Identified by Monoclonal Antibody Ki-67, KIA, MKI67, Proliferation Related Ki-67 Antigen)
Sign In for Pricing
View Details 
RC206093L4V 200 µL
UFL1 (NM_015323) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details